Sort
30,917 grants matching “tumor microenvironment”
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma
$402,500Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
THE FUNCTION AND REGULATION OF HISTIDINE DECARBOXYLASE IN GUT INFLAMMATION
$402,500Timothy Cragin Wang · Columbia University Health Sciences · R01 · FY2011 · DK
Innate Antiviral Signals for Cancer Immunotherapy
$402,500Matthias Gromeier · Duke University · R01 · FY2025 · NS
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma
$402,500Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Mechanism and therapeutic potential of microglia regulation in glioblastoma
$402,500Peiwen Chen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma
$402,500Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · NS
Synergistic microglial activation and tumor cell killing for improved GBM response
$402,500Vidyalakshmi Chandramohan · Duke University · R01 · FY2022 · NS
Synergistic microglial activation and tumor cell killing for improved GBM response
$402,500Vidyalakshmi Chandramohan · Duke University · R01 · FY2021 · NS
Innate Antiviral Signals for Cancer Immunotherapy
$402,500Matthias Gromeier · Duke University · R01 · FY2023 · NS
Synergistic microglial activation and tumor cell killing for improved GBM response
$402,500Vidyalakshmi Chandramohan · Duke University · R01 · FY2025 · NS
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$402,467Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2024 · NS
Roles of Glial Autophagy in Breast Cancer Brain Metastasis
$402,424Chenran Wang · University Of Cincinnati · R01 · FY2023 · CA
In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors
$402,417Fumito Ito · University Of Southern California · R01 · FY2022 · CA
Development of a PET CCR2 Imaging Agent to Profile PDAC Microenvironment
$402,401Mark Myron Goodman · Emory University · R21 · FY2024 · CA
Targeting CXCR2+ PMN-MDSCs for immunotherapy of hepatoblastoma
$402,400Xin Chen · University Of Hawaii At Manoa · R21 · FY2025 · CA
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
$402,394Michael A Dyer · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Regulation of collagen linearization during cancer progression and metastasis
$402,394Myriam Labelle · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$402,394Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$402,394Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Regulation of collagen linearization during cancer progression and metastasis
$402,394Myriam Labelle · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
$402,394Michael A Dyer · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
AKT pathway as a therapeutic tumor vessel target
$402,342Laura E Benjamin · Beth Israel Deaconess Medical Center · R01 · FY2009 · CA
Tumor Cell Biology Training Program
$402,313Gay Miriam Crooks · University Of California Los Angeles · T32 · FY2015 · CA
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
$402,301Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · NS
Project 3: Skin hypoxia, MCPyV infection, and MCC tumorigenesis
$402,262Jianxin You · University Of Pennsylvania · P01 · FY2025 · CA